Apollomics (APLM) Assets Average (2023 - 2025)
Apollomics' (APLM) quarterly Assets Average came in at $8.9 million in Q4 2025, down 62.59% year-over-year from $23.8 million in Q4 2024, and down 26.36% quarter-over-quarter from $12.1 million in Q2 2025.
Analysis
Apollomics (APLM) Assets Average (2023 - 2025) Analysis & Trends
Apollomics (APLM) has reported Assets Average for 3 consecutive years, with $8.9 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Assets Average fell 62.59% year-over-year to $8.9 million in Q4 2025; TTM through Dec 2025 was $8.9 million, a 62.59% decrease from a year earlier, with the FY2025 full-year figure at $9.9 million, down 28.87% from the prior year.
- Assets Average was $8.9 million for Q4 2025 at Apollomics, down from $12.1 million in the prior quarter.
- Over five years, Assets Average peaked at $73.9 million in Q2 2023 and troughed at $8.9 million in Q4 2025.
- A 3-year average of $31.1 million and a median of $24.3 million in 2024 frame the typical range for Assets Average.
- The widest YoY moves for Assets Average: up 44.66% in 2024, down 66.64% in 2024.
- Over 3 years, Assets Average stood at $43.1 million in 2023, then plunged by 44.66% to $23.8 million in 2024, then tumbled by 62.59% to $8.9 million in 2025.
- The last three Assets Average figures came in at $8.9 million (Q4 2025), $12.1 million (Q2 2025), and $23.8 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.51 Bn |
| 10 | Apollomics | 34.50 Mn | 31.23 Mn | - | 8.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.92 Mn |
| Jun 30, 2025 | 12.11 Mn |
| Dec 31, 2024 | 23.84 Mn |
| Jun 30, 2024 | 24.67 Mn |
| Dec 31, 2023 | 43.07 Mn |
| Jun 30, 2023 | 73.93 Mn |